Atai Life Sciences Profit Margin 2020-2023 | ATAI

Current and historical gross margin, operating margin and net profit margin for Atai Life Sciences (ATAI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Atai Life Sciences net profit margin as of September 30, 2023 is -12810.51%.
Atai Life Sciences Annual Profit Margins
Atai Life Sciences Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.329B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $15.996B 9.68
Quest Diagnostics (DGX) United States $14.102B 14.58
DaVita (DVA) United States $11.194B 15.23
Chemed (CHE) United States $9.133B 28.74
Encompass Health (EHC) United States $7.980B 21.89
Elanco Animal Health (ELAN) United States $6.611B 15.07
Option Care Health (OPCH) United States $5.261B 20.59
RadNet (RDNT) United States $3.273B 95.60
Amedisys (AMED) United States $2.971B 21.20
LifeStance Health (LFST) United States $2.166B 0.00
Astrana Health (ASTH) United States $2.073B 26.16
Addus HomeCare (ADUS) United States $1.568B 24.03
U.S Physical Therapy (USPH) United States $1.478B 38.33
Pennant (PNTG) United States $0.608B 35.10
Aveanna Healthcare Holdings (AVAH) United States $0.427B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.010B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00